{"AllianceGenome": "16132", "HGNC": "16132", "MIM": "617583", "_id": "140809", "_version": 2, "accession": {"genomic": ["AL121758.24", "CH471133.3", "CP068258.2", "NC_000020.11", "NC_060944.1"], "protein": ["AAH17001.1", "AAH32604.1", "AAH47707.1", "AAR87853.1", "BAC05302.1", "BAG34990.1", "CAD38799.1", "NP_542763.1", "Q9BYN0.2"], "rna": ["AF075053.1", "AK098418.1", "AK127435.1", "AK312054.1", "AL833944.1", "AY427953.1", "BC017001.1", "BC032604.1", "BC047707.1", "BU170568.1", "NM_080725.3"], "translation": [{"protein": "AAH17001.1", "rna": "BC017001.1"}, {"protein": "AAH32604.1", "rna": "BC032604.1"}, {"protein": "BAG34990.1", "rna": "AK312054.1"}, {"protein": "AAR87853.1", "rna": "AY427953.1"}, {"protein": "AAH47707.1", "rna": "BC047707.1"}, {"protein": "CAD38799.1", "rna": "AL833944.1"}, {"protein": "BAC05302.1", "rna": "AK098418.1"}, {"protein": "NP_542763.1", "rna": "NM_080725.3"}]}, "alias": ["C20orf139", "Npn3", "SRX", "SRX1"], "ec": "1.8.98.2", "ensembl": {"gene": "ENSG00000271303", "protein": "ENSP00000371388", "transcript": "ENST00000381962", "translation": [{"protein": "ENSP00000371388", "rna": "ENST00000381962"}], "type_of_gene": "protein_coding"}, "entrezgene": "140809", "exac": {"_license": "http://bit.ly/2H9c4hg", "all": {"exp_lof": 3.29150551074, "exp_mis": 50.0032639699, "exp_syn": 28.4044170644, "lof_z": 0.159161906158352, "mis_z": 1.03777438882845, "mu_lof": 2.67787005477e-07, "mu_mis": 7.2003815643e-06, "mu_syn": 4.18549014413e-06, "n_lof": 3.0, "n_mis": 35.0, "n_syn": 18.0, "p_li": 0.00865787938463754, "p_null": 0.418543345616268, "p_rec": 0.572798774999094, "syn_z": 1.21024793057392}, "bp": 414, "cds_end": 633829, "cds_start": 629357, "n_exons": 2, "nonpsych": {"exp_lof": 2.94945954245, "exp_mis": 45.2281097657, "exp_syn": 25.6790669796, "lof_z": -0.0289014707792201, "mis_z": 0.992099561134837, "mu_lof": 2.67787005477e-07, "mu_mis": 7.2003815643e-06, "mu_syn": 4.18549014413e-06, "n_lof": 3.0, "n_mis": 32.0, "n_syn": 17.0, "p_li": 0.00803241002766676, "p_null": 0.464659895213305, "p_rec": 0.527307694759028, "syn_z": 1.07831852956944}, "nontcga": {"exp_lof": 3.02529310601, "exp_mis": 46.0001140753, "exp_syn": 26.1291719421, "lof_z": 0.581494392274567, "mis_z": 0.954943117369458, "mu_lof": 2.67787005477e-07, "mu_mis": 7.2003815643e-06, "mu_syn": 4.18549014413e-06, "n_lof": 2.0, "n_mis": 33.0, "n_syn": 16.0, "p_li": 0.0514327083489426, "p_null": 0.254856663312586, "p_rec": 0.693710628338471, "syn_z": 1.2546810520041}, "transcript": "ENST00000381962.3"}, "exons": [{"cdsend": 653185, "cdsstart": 648713, "chr": "20", "position": [[646623, 648917], [652975, 653200]], "strand": -1, "transcript": "NM_080725", "txend": 653200, "txstart": 646623}], "exons_hg19": [{"cdsend": 633829, "cdsstart": 629357, "chr": "20", "position": [[627267, 629561], [633619, 633844]], "strand": -1, "transcript": "NM_080725", "txend": 633844, "txstart": 627267}], "generif": [{"pubmed": 15952770, "text": "The reduction of the cysteine sulfinic acid moiety within the active site of the peroxiredoxin by sulfiredoxin involves novel sulfur chemistry and the use of ATP and Mg(2+)."}, {"pubmed": 16565085, "text": "analysis of the reduction of cysteine sulfinic acid of peroxiredoxin to cysteine by mammalian sulfiredoxin"}, {"pubmed": 16818657, "text": "Actin and protein tyrosine phosphatase 1B were identified in vitro as targets of sulfiredoxin 1 (Srx1)-dependent deglutathionylation."}, {"pubmed": 17176052, "text": "Aspartate-187 of peroxiredoxin (Prx) I is the catalytic residue responsible for ATP hydrolysis in the cysteinesulfinic acid reduction of Prx by human sulfiredoxin."}, {"pubmed": 18172504, "text": "2.6 A crystal structure of the human Srx-PrxI complex [Srx]"}, {"pubmed": 18579529, "text": "Reduction of cysteine sulfinic acid in peroxiredoxin by sulfiredoxin proceeds directly through a sulfinic phosphoryl ester intermediate"}, {"pubmed": 18593714, "text": "analysis of a protein thiosulfinate intermediate in the reduction of cysteine sulfinic acid in peroxiredoxin by human sulfiredoxin"}, {"pubmed": 19027064, "text": "decreased expression in lungs from patients with chronic obstructive pulmonary disorder"}, {"pubmed": 19057013, "text": "The current study identifies Sulfiredoxin as a unique target of activator protein-1 (AP-1) activation and TAM67 inhibition."}, {"pubmed": 19561357, "text": "Deglutathionylation of 2-Cys Prx is specifically catalyzed by Srx."}, {"pubmed": 19812042, "text": "Studies present the 2.1 A crystal structure of human Srx in complex with PrxI, ATP, and Mg(2+)."}, {"pubmed": 20718723, "text": "sulfiredoxin 1 is associatd with the pathogenesis of human pulmonary fibrosis."}, {"pubmed": 21487000, "text": "Srx-Prx IV axis is critical for lung cancer maintenance and metastasis, suggesting that targeting the Srx-Prx IV axis may provide unique effective strategies for cancer prevention and treatment."}, {"pubmed": 21742584, "text": "Real-time PCR validated that up-regulation of sulphiredoxin 1 homolog (SRXN1), hemeoxygenase 1 (HMOX1), and breast carcinoma amplified sequence 3 (BCAS3) were consistently modulated."}, {"pubmed": 21943684, "text": "Smokers and ex-smokers had significantly more sulfiredoxin expression in their tumors and in patients receiving cytostatic drugs or radiation therapy, sulfiredoxin expression predicted a poor prognosis."}, {"pubmed": 22086924, "text": "Srx functions as a novel component to maintain the balance between H2O2 production and elimination"}, {"pubmed": 22879602, "text": "Gemfibrozil, a lipid-lowering drug, increases myelin genes in human oligodendrocytes via peroxisome proliferator-activated receptor-beta."}, {"pubmed": 22934964, "text": "SRX forms a complex with S100A4 (and has stronger affinity for S-glutathionylated S100A4), regulates its activity, and mediates redox regulation of the interaction of S100A4 with nonmuscle myosin heavy chain II-A."}, {"pubmed": 22964583, "text": "NRF2 and SRXN1 genetic polymorphisms are associated with breast cancer risk and survival"}, {"pubmed": 25460739, "text": "This review will highlight the cumulative effects of sulfiredoxin in various systemic disorders with a strong emphasis on its target activity and the factors influencing its expression in such conditions."}, {"pubmed": 26170166, "text": "This review will summarize the molecular basis of differences in the affinity of Srx for individual Prx and the role of individual component of the Srx-Prx system in tumor progression and metastasis."}, {"pubmed": 26290602, "text": "Study shows that Srx plays a critical oncogenic role to promote cell invasion and metastasis, which is at least partially due to its stimulation of the MAPK pathway through EGFR deacetylation."}, {"pubmed": 27226772, "text": "rs6053666 of SRXN1 is associated with cerebrovascular disease in a Finnish cohort"}, {"pubmed": 27377607, "text": "The analysis of SXR polymorphism is a promising tool to predict both the favourable response to corticosteroids and the risk of developing steroid resistance"}, {"pubmed": 27821734, "text": "Study identify a role for Srxn1 as a denitrosylase for neuronal Prx2. Finding points to the NO/Srxn1 pair in a previously unrecognized redox cycle that modulates Prx2 peroxidase activity."}, {"pubmed": 28202395, "text": "Increased expression of Srx protects peroxiredoxins against hyperoxidation in the early stage of hyperglycaemia."}, {"pubmed": 28274319, "text": "The up-regulated expression of Srx was significantly associated with lymph node metastasis, infiltration of vessels, and the depth of cancer invasion."}, {"pubmed": 28351308, "text": "We silenced Srx by short hairpin RNA in HeLa and SiHa cells. Diminished Srx expression upregulated E-cadherin expression. The cell invasion and migration activity in the ShSrx group were obviously decreased in HeLa and SiHa cells."}, {"pubmed": 28448437, "text": "Wnt/beta-catenin pathway was stimulated by sulfiredoxin in tumor cell line, with activation of CD44-its target genes-resulting in the promotion of invasion and migration in cervical cancer cell lines."}, {"pubmed": 29441509, "text": "NRF2, DJ1 and SRNX1 are commonly expressed in diffusely infiltrating astrocytomas and they can be used in predicting patient prognosis."}, {"pubmed": 30863778, "text": "Srx expression, MDA levels, and ROS levels in BGC823 cells were markedly inhibited upon treatment with diallyl trisulfide (DATS), a major constituent of garlic oil with proven anticancer effects. These results suggest that Srx may be an oxidative stress marker. Antioxidation may account for the anticancer potential of garlic."}, {"pubmed": 31000628, "text": "Sulfiredoxin exhibits an increased association with TXNDC5, facilitating the retention of Srx in the endoplasmic reticulum. The cellular levels of Srx and TXNDC5 may be useful as biomarkers to predict the survival of individuals with lung cancer."}, {"pubmed": 32411320, "text": "Sulfiredoxin as a Potential Therapeutic Target for Advanced and Metastatic Prostate Cancer."}, {"pubmed": 32746503, "text": "SRXN1 stimulates hepatocellular carcinoma tumorigenesis and metastasis through modulating ROS/p65/BTG2 signalling."}, {"pubmed": 32955798, "text": "Sulfiredoxin-1 is a promising novel prognostic biomarker for hepatocellular carcinoma."}, {"pubmed": 37017121, "text": "CircABCA13 acts as a miR-4429 sponge to facilitate esophageal squamous cell carcinoma development by stabilizing SRXN1."}, {"pubmed": 37726767, "text": "Antioxidative stress protein SRXN1 can be used as a radiotherapy prognostic marker for prostate cancer."}, {"pubmed": 38852489, "text": "Unraveling the role of sulfiredoxin-1 in early-onset preeclampsia: A key player in trophoblast ferroptosis."}, {"pubmed": 39029574, "text": "Sulfiredoxin-1 promotes the growth of hepatocellular carcinoma by inhibiting TFEB-mediated autophagy and lysosome biogenesis."}], "genomic_pos": {"chr": "20", "end": 653200, "ensemblgene": "ENSG00000271303", "start": 646615, "strand": -1}, "genomic_pos_hg19": {"chr": "20", "end": 634014, "start": 627259, "strand": -1}, "go": {"BP": [{"evidence": "IDA", "gocategory": "BP", "id": "GO:0006979", "pubmed": 15448164, "qualifier": "involved_in", "term": "response to oxidative stress"}, {"evidence": "IBA", "gocategory": "BP", "id": "GO:0034599", "qualifier": "involved_in", "term": "cellular response to oxidative stress"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:0098869", "qualifier": "involved_in", "term": "cellular oxidant detoxification"}], "CC": [{"evidence": "IBA", "gocategory": "CC", "id": "GO:0005737", "qualifier": "is_active_in", "term": "cytoplasm"}, {"evidence": "TAS", "gocategory": "CC", "id": "GO:0005789", "qualifier": "located_in", "term": "endoplasmic reticulum membrane"}, {"evidence": "IDA", "gocategory": "CC", "id": "GO:0005829", "pubmed": 15448164, "qualifier": "located_in", "term": "cytosol"}], "MF": [{"category": "MF", "evidence": "IPI", "id": "GO:0005515", "pubmed": 18172504, "qualifier": "enables", "term": "protein binding"}, {"category": "MF", "evidence": "IEA", "id": "GO:0005524", "qualifier": "enables", "term": "ATP binding"}, {"category": "MF", "evidence": "IDA", "id": "GO:0016667", "pubmed": 15448164, "qualifier": "enables", "term": "oxidoreductase activity, acting on a sulfur group of donors"}, {"category": "MF", "evidence": "IBA", "id": "GO:0032542", "qualifier": "enables", "term": "sulfiredoxin activity"}, {"category": "MF", "evidence": "TAS", "id": "GO:0032542", "qualifier": "enables", "term": "sulfiredoxin activity"}]}, "homologene": {"genes": [[7227, 32768], [7955, 100331561], [9031, 100858692], [9544, 714997], [9598, 469853], [9606, 140809], [9615, 100686728], [9913, 531606], [10090, 76650], [10116, 296271]], "id": 32722}, "interpro": [{"desc": "ParB/Sulfiredoxin", "id": "IPR003115", "short_desc": "ParB/Sulfiredoxin_dom"}, {"desc": "Sulfiredoxin", "id": "IPR016692", "short_desc": "Sulfiredoxin"}, {"desc": "ParB/Sulfiredoxin superfamily", "id": "IPR036086", "short_desc": "ParB/Sulfiredoxin_sf"}], "ipi": "IPI00168554", "map_location": "20p13", "name": "sulfiredoxin 1", "other_names": ["sulfiredoxin-1", "sulphiredoxin"], "pantherdb": {"HGNC": "16132", "_license": "http://pantherdb.org/tou.jsp", "ortholog": [{"MGI": "104971", "ortholog_type": "LDO", "panther_family": "PTHR21348", "taxid": 10090, "uniprot_kb": "Q9D975"}, {"Ensembl": "ENSRNOG00000031167", "ortholog_type": "LDO", "panther_family": "PTHR21348", "taxid": 10116, "uniprot_kb": "Q7TP44"}, {"Ensembl": "ENSGALG00000054306", "ortholog_type": "LDO", "panther_family": "PTHR21348", "taxid": 9031, "uniprot_kb": "A0A3Q2UDS8"}, {"ZFIN": "ZDB-GENE-091230-2", "ortholog_type": "LDO", "panther_family": "PTHR21348", "taxid": 7955, "uniprot_kb": "E7FBQ8"}, {"FlyBase": "FBgn0030876", "ortholog_type": "LDO", "panther_family": "PTHR21348", "taxid": 7227, "uniprot_kb": "Q9VX10"}, {"SGD": "S000001569", "ortholog_type": "LDO", "panther_family": "PTHR21348", "taxid": 4932, "uniprot_kb": "P36077"}, {"PomBase": "SPBC106.02c", "ortholog_type": "LDO", "panther_family": "PTHR21348", "taxid": 4896, "uniprot_kb": "Q9URV9"}, {"EnsemblGenome": "AT1G31170", "ortholog_type": "LDO", "panther_family": "PTHR21348", "taxid": 3702, "uniprot_kb": "Q8GY89"}], "uniprot_kb": "Q9BYN0"}, "pathway": {"reactome": [{"id": "R-HSA-2262752", "name": "Cellular responses to stress"}, {"id": "R-HSA-8953897", "name": "Cellular responses to stimuli"}, {"id": "R-HSA-9711123", "name": "Cellular response to chemical stress"}, {"id": "R-HSA-9755511", "name": "KEAP1-NFE2L2 pathway"}, {"id": "R-HSA-9759194", "name": "Nuclear events mediated by NFE2L2"}, {"id": "R-HSA-9818027", "name": "NFE2L2 regulating anti-oxidant/detoxification enzymes"}], "wikipathways": [{"id": "WP2882", "name": "Nuclear Receptors Meta-Pathway"}, {"id": "WP2884", "name": "NRF2 pathway"}, {"id": "WP3612", "name": "Photodynamic therapy-induced NFE2L2 (NRF2) survival signaling"}]}, "pdb": ["1XW3", "1XW4", "1YZS", "2B6F", "2RII", "3CYI", "3HY2", "7LJ1"], "pharmgkb": "PA25681", "pharos": {"target_id": 4136, "tdl": "Tbio"}, "reagent": {"GNF_hs-Origene": {"id": "GNF048336", "relationship": "is"}, "GNF_mm+hs-MGC": [{"id": "GNF001605", "relationship": "is"}, {"id": "GNF131115", "relationship": "is"}], "GNF_mm+hs_RetroCDNA": {"id": "GNF239514", "relationship": "is"}}, "refseq": {"genomic": ["NC_000020.11", "NC_060944.1"], "protein": "NP_542763.1", "rna": "NM_080725.3", "translation": {"protein": "NP_542763.1", "rna": "NM_080725.3"}}, "reporter": {"GNF1H": "gnf1h06537_at", "HG-U133_Plus_2": "225252_at", "HTA-2_0": "TC20000544.hg.1", "HuEx-1_0": ["3894316", "3894318", "3894320", "3894322", "3894335"], "HuGene-1_1": "8064375", "HuGene-2_1": "16916352"}, "summary": "Enables oxidoreductase activity, acting on a sulfur group of donors. Involved in response to oxidative stress. Located in cytosol. [provided by Alliance of Genome Resources, Apr 2022]", "symbol": "SRXN1", "taxid": 9606, "type_of_gene": "protein-coding", "umls": {"cui": "C1823127"}, "unigene": "Hs.516830", "uniprot": {"Swiss-Prot": "Q9BYN0"}, "wikipedia": {"url_stub": "SRXN1"}}